Product Information
XERAC AC 6.25% SOLUTION is a generic product labeled by Person and Covey, priced at $0.2173 per ML under NDC 00096070935. Its NADAC has been published 411 times since Nov 28, 2013.
Strength
.0625 g/g
Manufacturer
Person and CoveyNDC
00096070935
Classification
Generic
Dosage Form
LIQUID
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
ALUMINUM CHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M019On Market Since
6/1/1996
Price Statistics
The NADAC for XERAC AC 6.25% SOLUTION has been published 411 times since Nov 28, 2013, and over the history we have for it it has risen 28.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2173 per ML |
|---|---|
| All-time high | $0.2180 (May 13, 2026) |
| All-time low | $0.1615 (Jan 22, 2014) |
| 52-week high | $0.2180 |
| 52-week low | $0.2042 |
| Median price | $0.1698 |
| Average price | $0.1798 |
| Largest weekly change | +17.8% (Apr 17, 2024) |
| Weeks tracked | 411 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Person and Covey manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Xerac AC market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of XERAC AC 6.25% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for XERAC AC 6.25% SOLUTION, manufactured by Person and Covey, is $0.2173 per ML (NDC 00096070935), effective Sep 30, 2026.
How has the price of XERAC AC 6.25% SOLUTION changed over time?
Over the history we have for it, the NADAC for XERAC AC 6.25% SOLUTION has risen 28.8%. It has been tracked across 411 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for XERAC AC 6.25% SOLUTION?
Since Nov 28, 2013, the NADAC for XERAC AC 6.25% SOLUTION has ranged from a low of $0.1615 (Jan 22, 2014) to a high of $0.2180 (May 13, 2026), with a median of $0.1698 per ML.
Are there cheaper alternatives to XERAC AC 6.25% SOLUTION?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, XERAC AC 6.25% SOLUTION, is $0.1720 per ML — about 21% below XERAC AC 6.25% SOLUTION.
Who manufactures XERAC AC 6.25% SOLUTION?
XERAC AC 6.25% SOLUTION (NDC 00096070935) is labeled by Person and Covey, and CMS classifies it as a generic product.